TIVICAY HIV medication carton mislabeled with incorrect expiration date
GlaxoSmithKline recalls TIVICAY cartons nationwide with incorrect expiration date on packaging. The carton label shows May 2026, but the correct expiration on the bottle is April 2025.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a minor labeling error on carton packaging only, with no reported illnesses or injuries. The actual medication expiration date (April 2025) is correct on the bottle label; only the carton label is incorrect. Per FDA Class III classification and the severity rubric, this constitutes a Moderate recall.
Plain-English summary
GlaxoSmithKline LLC is recalling TIVICAY (dolutegravir sodium) 5mg Tablets for Oral Suspension nationwide. The carton packaging for affected units displays an incorrect expiration date of May 2026, while the correct expiration date shown on the tablet bottle label inside the carton is April 2025.
The recall affects 463 cartons of TIVICAY PD distributed nationwide within the United States. Each carton contains one bottle of 60 tablets, one 30-mL dosing cup, and one 10-mL oral dosing syringe. The affected lot number is AG4M.
The labeling discrepancy could lead patients to confusion about the true expiration date of their medication. Patients relying on the incorrect carton label may discard medication prematurely or continue using medication past its actual expiration date.
Patients and healthcare providers should refer to the expiration date on the tablet bottle label (April 2025), not the carton, when determining medication validity. Persons who have TIVICAY cartons with lot AG4M bearing an expiration date of May 2026 should contact their pharmacy or healthcare provider for replacement.
The recalled product
- Product
- TIVICAY (DOLUTEGRAVIR SODIUM)
- Brand
- TIVICAY
- Manufacturer
- GlaxoSmithKline LLC
- Category
- Drug — Antiretroviral
- Hazard
- Affected units
- 463
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: AG4M
- Labeled Expiry date on carton May 2026
- correct Exp. Date 04/2025
UPCs (3)
- 0349702227132
- 0349702226135
- 0349702228139
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · TIVICAY
- ModerateDrug Recall: Tivicay Tablets with Incorrect Expiration Date on Label
FDA (Drugs) · 2022-06-01
- ModerateViiv Healthcare Recalls Tivicay Tablets Due to Cross-Contamination with Promacta
FDA (Drugs) · 2014-04-09
Same manufacturer · GlaxoSmithKline LLC
See all →- ModerateAnoro Ellipta inhalation powder recalled for failed release testing defect
FDA (Drugs) · 2024-01-03
- HighGlaxoSmithKline Recalls Ventolin HFA Inhalers Due to Defective Delivery System
FDA (Drugs) · 2017-05-31
- ModerateGlaxoSmithKline Recalls Ventolin Inhalers Due to Defective Delivery System
FDA (Drugs) · 2017-04-12
- SevereGlaxoSmithKline Recalls Bactroban Nasal Ointment Due to Penicillin Contamination
FDA (Drugs) · 2016-07-27
- SevereGlaxoSmithKline Recalls Bactroban Ointment Due to Penicillin Cross-Contamination
FDA (Drugs) · 2016-07-27
Same hazard · mislabeling
See all →- ModerateOrthofix MINIRAIL External Fixation Devices Incorrectly Labeled
FDA (Devices) · 2026-07-22
- ModerateWise Onion Rings recalled for undeclared food color additives
FDA (Food) · 2026-07-15
- HighBakr Brown Butter Chocolate Chunk Cookie Dough Recalled for Undeclared Soy
FDA (Food) · 2026-07-15
- HighStapes prosthesis pistons carry an incorrect functional length on labeling
FDA (Devices) · 2026-06-10
- HighMedline eye trays contain insulin syringes labeled as tuberculin syringes
FDA (Devices) · 2026-06-03